Atlas Trials

Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population

Clinical trial NCT01191112 · COMPLETED

Trial details

NCT number
NCT01191112
Sponsor
Abbott Nutrition
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastrointestinal DiseasesFeeding Intolerance
Start date
2011-01-01
Primary completion
2011-11-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.